Insmed Incorporated (INSM) Analyst & Key Data

Analyst Consensus

Buy53 analysts

Buy

Updated Sep 12, 2026

Total Analysts53

Buy

33

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$129.41

Median Target+59.53%

$206.45

Potential upside vs current price

Current Stock Price

$129.41

Median Target+59.53%

$206.45

Potential upside vs current price

Analyst Consensus

Buy53 analysts

Buy

Updated Sep 12, 2026

Total Analysts53

Buy

33

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$129.41

Median Target+59.53%

$206.45

Potential upside vs current price

Current Stock Price

$129.41

Median Target+59.53%

$206.45

Potential upside vs current price